News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
206,986 Results
Type
Article (9743)
Company Profile (26)
Press Release (197214)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (59160)
Career Advice (660)
Deals (11274)
Drug Delivery (28)
Drug Development (29197)
Employer Resources (40)
FDA (5024)
Job Trends (4614)
News (102350)
Policy (8129)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (526)
Accelerated approval (24)
ADA (32)
Adcomms (9)
Allergies (93)
Alliances (7929)
ALS (116)
Alzheimer's disease (747)
Antibody-drug conjugate (ADC) (288)
Approvals (5491)
Artificial intelligence (351)
ASCO (224)
Autoimmune disease (195)
Automation (27)
Bankruptcy (78)
Best Places to Work (4096)
BIOSECURE Act (3)
Biosimilars (146)
Biotechnology (21)
Bladder cancer (168)
Brain cancer (34)
Breast cancer (541)
Cancer (3706)
Cardiovascular disease (282)
Career advice (544)
Career pathing (11)
CAR-T (159)
CDC (9)
Celiac Disease (2)
Cell therapy (443)
Cervical cancer (32)
Clinical research (28792)
Collaboration (1036)
Company closure (2)
Compensation (699)
Complete response letters (25)
COVID-19 (899)
CRISPR (53)
C-suite (475)
Cystic fibrosis (66)
Data (5509)
Decentralized trials (1)
Denatured (1)
Depression (85)
Dermatology (61)
Diabetes (346)
Diagnostics (2149)
Digital health (25)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (153)
Drug pricing (53)
Drug shortages (12)
Duchenne muscular dystrophy (175)
Earnings (49146)
Editorial (16)
Employer branding (8)
Employer resources (35)
Events (32019)
Executive appointments (520)
FDA (7288)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (862)
Gene editing (110)
Generative AI (18)
Gene therapy (341)
GLP-1 (541)
Government (1217)
Grass and pollen (4)
Guidances (379)
Healthcare (5432)
Hematology (98)
HIV (62)
Huntington's disease (21)
IgA nephropathy (64)
Immunology and inflammation (123)
Immuno-oncology (54)
Indications (121)
Infectious disease (1080)
Inflammatory bowel disease (107)
Inflation Reduction Act (5)
Influenza (59)
Intellectual property (99)
Interviews (127)
IPO (7195)
IRA (14)
Job creations (792)
Job search strategy (466)
JPM (20)
Kidney cancer (15)
Labor market (52)
Layoffs (166)
Leadership (8)
Legal (1488)
Liver cancer (48)
Longevity (10)
Lung cancer (551)
Lymphoma (332)
Machine learning (30)
Management (10)
Manufacturing (406)
MASH (108)
Medical device (4307)
Medtech (4373)
Mergers & acquisitions (4777)
Metabolic disorders (835)
mRNA (70)
Multiple sclerosis (132)
NASH (6)
Neurodegenerative disease (229)
Neuropsychiatric disorders (64)
Neuroscience (1605)
Neurotech (1)
NextGen: Class of 2026 (1487)
Non-profit (1075)
Now hiring (14)
Obesity (374)
Opinion (50)
Ovarian cancer (122)
Pain (117)
Pancreatic cancer (176)
Parkinson's disease (208)
Partnered (6)
Patents (218)
Patient recruitment (353)
Peanut (30)
People (7682)
Pharmaceutical (7)
Pharmacy benefit managers (13)
Phase 1 (7573)
Phase 2 (12382)
Phase 3 (11191)
Pipeline (6298)
Policy (65)
Postmarket research (1068)
Preclinical (2422)
Press Release (27)
Prostate cancer (200)
Psychedelics (12)
Radiopharmaceuticals (110)
Rare diseases (573)
Real estate (921)
Recruiting (16)
Regulatory (7979)
Reports (19)
Research institute (534)
Resumes & cover letters (112)
Rett syndrome (37)
RNA editing (7)
RSV (54)
Schizophrenia (103)
Series A (132)
Series B (115)
Service/supplier (3)
Sickle cell disease (72)
Special edition (11)
Spinal muscular atrophy (100)
Sponsored (13)
Startups (648)
State (1)
Stomach cancer (8)
Supply chain (60)
Tariffs (21)
The Weekly (8)
Vaccines (460)
Venture capital (39)
Weight loss (250)
Women's health (61)
Worklife (10)
Date
Today (17)
Last 7 days (332)
Last 30 days (1543)
Last 365 days (16472)
2026 (8076)
2025 (16918)
2024 (14758)
2023 (14315)
2022 (16776)
2021 (16233)
2020 (15539)
2019 (12784)
2018 (9784)
2017 (9333)
2016 (7965)
2015 (9632)
2014 (7086)
2013 (5215)
2012 (5911)
2011 (6161)
2010 (5233)
Location
Africa (224)
Alabama (21)
Alaska (2)
Arizona (105)
Arkansas (6)
Asia (13148)
Australia (2271)
California (7653)
Canada (1732)
China (748)
Colorado (297)
Connecticut (390)
Delaware (310)
Europe (32306)
Florida (817)
Georgia (191)
Hawaii (3)
Idaho (14)
Illinois (627)
India (41)
Indiana (302)
Iowa (12)
Japan (414)
Kansas (65)
Kentucky (22)
Louisiana (38)
Maine (45)
Maryland (686)
Massachusetts (5457)
Michigan (130)
Minnesota (343)
Mississippi (3)
Missouri (76)
Montana (11)
Nebraska (7)
Nevada (87)
New Hampshire (38)
New Jersey (2110)
New Mexico (8)
New York (1826)
North Carolina (877)
North Dakota (4)
Northern California (3959)
Ohio (190)
Oklahoma (6)
Oregon (10)
Pennsylvania (1311)
Puerto Rico (8)
Rhode Island (20)
South America (329)
South Carolina (21)
Southern California (2954)
Tennessee (90)
Texas (1110)
United States (25531)
Utah (160)
Virginia (179)
Washington D.C. (34)
Washington State (600)
West Virginia (2)
Wisconsin (111)
206,986 Results for "6".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Company closure
6 biotechs that called it quits in Q1
Six biotechs based in California, Massachusetts, Washington and Denmark had to halt drug development efforts this year. One of their CEOs is now in an interim chief executive role at another biotech.
April 30, 2026
·
6 min read
·
Angela Gabriel
Job Trends
6 Companies Hiring in Cambridge
Looking for a biopharma job in Cambridge? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
March 11, 2026
·
1 min read
·
Angela Gabriel
Press Releases
Oligonucleotide CDMO Market Worth $6.73 Billion by 2029, Growing at 21.8% CAGR
June 10, 2026
·
1 min read
Press Releases
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - May 6, 2026
May 6, 2026
·
1 min read
Press Releases
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
May 18, 2026
·
4 min read
Mergers & acquisitions
Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend
With $6 billion left in firepower, Pfizer is planning transactions in the hundreds of millions to the low-billions range, particularly in internal medicine and immunology and inflammation, Guggenheim reported.
December 10, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Rejuvenate Bio Announces $6 Million Financing and Strategic R&D Collaboration with Merck Animal Health
June 8, 2026
·
2 min read
Mergers & acquisitions
GSK pays $10.6B for cancer biotech Nuvalent in industry’s second-biggest buy of the year
Nuvalent Bio is GSK’s third big-ticket purchase this year, after the pharma dropped $2.2 billion in January for RAPT Therapeutics and $950 million in February for 35Pharma.
June 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
LifeMD to Report First Quarter 2026 Financial Results on May 6
April 27, 2026
·
1 min read
Press Releases
QT Imaging Reports First Quarter 2026 Revenue of $6.5 Million
May 14, 2026
·
19 min read
1 of 20,699
Next
